Your request to link to rcsb for Ab%20N1G9

• 1CL7: anti hiv1 protease fab
• 1DL7: the structural basis of repertoire shift in an immune response to phosphocholine (10.1084/JEM.191.12.2101 )
• 1E6J: crystal structure of hiv-1 capsid protein (p24) in complex with fab13b5 (10.1016/S0969-2126(00)00507-4 )
• 1E6O: crystal structure of fab13b5 against hiv-1 capsid protein p24 (10.1016/S0969-2126(00)00507-4 )
• 1ETZ: the three-dimensional structure of an anti-sweetener fab, nc10.14, shows the extent of structural diversity in antigen recognition by immunoglobulins (10.1006/JMBI.2000.4083 )
• 1F11: f124 fab fragment from a monoclonal anti-pres2 antibody (10.1107/S0907444900008088 )
• 1F4W: crystal structure of an anti-carbohydrate antibody directed against vibrio cholerae o1 in complex with antigen (10.1073/PNAS.060022997 )
• 1F4X: crystal structure of an anti-carbohydrate antibody directed against vibrio cholerae o1 in complex with antigen (10.1073/PNAS.060022997 )
• 1F4Y: crystal structure of an anti-carbohydrate antibody directed against vibrio cholerae o1 in complex with antigen (10.1073/PNAS.060022997 )
• 1FBI: crystal structure of a cross-reaction complex between fab f9.13.7 and guinea-fowl lysozyme (10.1074/JBC.270.30.18067 )
• 1GIG: refined three-dimensional structure of the fab fragment of a murine igg1, lambda antibody (10.1107/S0907444994001903 )
• 1I8M: crystal structure of a recombinant anti-single-stranded dna antibody fragment complexed with dt5 (10.1006/JMBI.2001.5178 )
• 1IND: how the anti-(metal chelate) antibody cha255 is specific for the metal ion of its antigen: x-ray structures for two fab'(slash)hapten complexes with different metals in the chelate (10.1021/BI00092A004 )
• 1INE: how the anti-(metal chelate) antibody cha255 is specific for the metal ion of its antigen: x-ray structures for two fab'(slash)hapten complexes with different metals in the chelate (10.1021/BI00092A004 )
• 1IQW: crystal structure of the fab fragment of the mouse anti-human fas antibody hfe7a (10.1093/OXFORDJOURNALS.JBCHEM.A003068 )
• 1JFQ: antigen-binding fragment of the murine anti-phenylarsonate antibody 36-71, "fab 36-71"
• 1JN6: crystal structure of fab-estradiol complexes (10.1006/JMBI.2001.5284 )
• 1JNH: crystal structure of fab-estradiol complexes (10.1006/JMBI.2001.5284 )
• 1K4C: potassium channel kcsa-fab complex in high concentration of k+ (10.1038/35102009 )
• 1K4D: potassium channel kcsa-fab complex in low concentration of k+ (10.1038/35102009 )
• 1MFA: structure of a single-chain fv fragment complexed with a carbohydrate antigen at 1.7 angstroms resolution (10.1073/PNAS.91.14.6423 )
• 1MFB: high resolution structures of antibody fab fragment complexed with cell-surface oligosaccharide of pathogenic salmonella
• 1MFC: high resolution structures of antibody fab fragment complexed with cell-surface oligosaccharide of pathogenic salmonella
• 1MFD: the solution structure of a trisaccharide-antibody complex: comparison of nmr measurements with a crystal structure (10.1021/BI00183A023 )
• 1MFE: recognition of a cell-surface oligo-saccharide of pathogenic salmonella by an antibody fab fragment
• 1MLB: monoclonal antibody fab d44.1 raised against chicken egg-white lysozyme (10.1016/0022-2836(94)90046-9 )
• 1MLC: monoclonal antibody fab d44.1 raised against chicken egg- white lysozyme complexed with lysozyme (10.1016/0022-2836(94)90046-9 )
• 1NC2: crystal structure of monoclonal antibody 2d12.5 fab complexed with y- dota (10.1021/JA037236Y )
• 1NC4: crystal structure of monoclonal antibody 2d12.5 fab complexed with gd- dota (10.1021/JA037236Y )
• 1NGP: n1g9 (igg1-lambda) fab fragment complexed with (4-hydroxy-3- nitrophenyl) acetate (10.1006/JMBI.1995.0612 )
• 1NGQ: n1g9 (igg1-lambda) fab fragment (10.1006/JMBI.1995.0612 )
• 1NJ9: cocaine hydrolytic antibody 15a10 (10.1021/BI049495L )
• 1NQB: trivalent antibody fragment (10.1073/PNAS.94.18.9637 )
• 1OAQ: free conformation ab1 of the ige spe-7 (10.1126/SCIENCE.1079731 )
• 1OAR: fv ige spe-7 in complex with alizarin red (10.1126/SCIENCE.1079731 )
• 1OAU: fv structure of the ige spe-7 in complex with dnp-ser (immunising hapten) (10.1126/SCIENCE.1079731 )
• 1OAX: fv structure of the ige spe-7 in complex with acenaphthenequinone (10.1126/SCIENCE.1079731 )
• 1OAY: antibody multispecificity mediated by conformational diversity (10.1126/SCIENCE.1079731 )
• 1OAZ: ige fv spe7 complexed with a recombinant thioredoxin (10.1126/SCIENCE.1079731 )
• 1OCW: free conformation ab2 of the ige spe-7 (10.1126/SCIENCE.1079731 )
• 1P4B: three-dimensional structure of a single chain fv fragment complexed with the peptide gcn4(7p-14p). (10.1074/JBC.M309169200 )
• 1P4I: crystal structure of scfv against peptide gcn4 (10.1074/JBC.M309169200 )
• 1P7K: crystal structure of an anti-ssdna antigen-binding fragment (fab) bound to 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (hepes) (10.1002/PROT.20200 )
• 1PG7: murine 6a6 fab in complex with humanized anti-tissue factor d3h44 fab (10.1016/S0022-2836(03)00735-6 )
• 1Q0X: anti-morphine antibody 9b1 unliganded form (10.1016/J.JMB.2003.12.084 )
• 1Q0Y: anti-morphine antibody 9b1 complexed with morphine (10.1016/J.JMB.2003.12.084 )
• 1QFU: influenza virus hemagglutinin complexed with a neutralizing antibody (10.1038/9299 )
• 1R3I: potassium channel kcsa-fab complex in rb+ (10.1016/J.JMB.2003.09.022 )
• 1R3J: potassium channel kcsa-fab complex in high concentration of tl+ (10.1016/J.JMB.2003.09.022 )
• 1R3K: potassium channel kcsa-fab complex in low concentration of tl+ (10.1016/J.JMB.2003.09.022 )
• 1R3L: potassium channel kcsa-fab complex in cs+ (10.1016/J.JMB.2003.09.022 )
• 1S5H: potassium channel kcsa-fab complex t75c mutant in k+ (10.1016/J.JMB.2004.03.020 )
• 1SM3: crystal structure of the tumor specific antibody sm3 complex with its peptide epitope (10.1006/JMBI.1998.2209 )
• 1XF2: structure of fab dna-1 complexed with dt3 (10.1016/J.JMB.2005.02.008 )
• 1XF3: structure of ligand-free fab dna-1 in space group p65 (10.1016/J.JMB.2005.02.008 )
• 1XF4: structure of ligand-free fab dna-1 in space group p321 solved from crystals with perfect hemihedral twinning (10.1016/J.JMB.2005.02.008 )
• 1XGY: crystal structure of anti-meta i rhodopsin fab fragment k42- 41l (10.1074/JBC.M510175200 )
• 1YUH: fab fragment (10.1016/0161-5890(95)00063-1 )
• 1Z3G: crystal structure of complex between pvs25 and fab fragment of malaria transmission blocking antibody 2a8 (10.1038/NSMB1024 )
• 1ZWI: structure of mutant kcsa potassium channel (10.1038/NSMB1069 )
• 2A6D: crystal structure analysis of the anti-arsonate germline antibody 36- 65 in complex with a phage display derived dodecapeptide rlliadppspre (10.1016/J.IMMUNI.2006.02.010 )
• 2A6I: crystal structure analysis of the anti-arsonate germline antibody 36- 65 in complex with a phage display derived dodecapeptide klasipthtspl (10.1016/J.IMMUNI.2006.02.010 )
• 2A6J: crystal structure analysis of the anti-arsonate germline antibody 36- 65 (10.1016/J.IMMUNI.2006.02.010 )
• 2A6K: crystal structure analysis of the germline antibody 36-65 fab in complex with the dodecapeptide slgdnltnhnlr (10.1016/J.IMMUNI.2006.02.010 )
• 2ATK: structure of a mutant kcsa k+ channel (10.1038/NSMB1069 )
• 2BJM: spe7:anthrone complex (10.1073/PNAS.0500909102 )
• 2BOB: potassium channel kcsa-fab complex in thallium with tetrabutylammonium (tba) (10.1038/NSMB929 )
• 2BOC: potassium channel kcsa-fab complex in thallium with tetraethylarsonium (teas) (10.1038/NSMB929 )
• 2DWD: crystal structure of kcsa-fab-tba complex in tl+ (10.1016/J.JMB.2006.11.081 )
• 2DWE: crystal structure of kcsa-fab-tba complex in rb+ (10.1016/J.JMB.2006.11.081 )
• 2FR4: structure of fab dna-1 complexed with a stem-loop dna ligand (10.1016/J.JMB.2007.09.084 )
• 2H8P: structure of a k channel with an amide to ester substitution in the selectivity filter (10.1021/JA0631955 )
• 2HFE: rb+ complex of a k channel with an amide to ester substitution in the selectivity filter (10.1021/JA0631955 )
• 2HG5: cs+ complex of a k channel with an amide to ester substitution in the selectivity filter (10.1021/JA0631955 )
• 2HJF: potassium channel kcsa-fab complex with tetrabutylammonium (tba) (10.1016/J.JMB.2006.09.069 )
• 2HVJ: crystal structure of kcsa-fab-tba complex in low k+ (10.1016/J.JMB.2006.11.081 )
• 2HVK: crystal structure of the kcsa-fab-tba complex in high k+ (10.1016/J.JMB.2006.11.081 )
• 2I9L: structure of fab 7d11 from a neutralizing antibody against the poxvirus l1 protein (10.1016/J.VIROL.2007.06.042 )
• 2IH1: ion selectivity in a semi-synthetic k+ channel locked in the conductive conformation (10.1126/SCIENCE.1133415 )
• 2IH3: ion selectivity in a semi-synthetic k+ channel locked in the conductive conformation (10.1126/SCIENCE.1133415 )
• 2ITC: potassium channel kcsa-fab complex in sodium chloride (10.1371/JOURNAL.PBIO.0050121 )
• 2ITD: potassium channel kcsa-fab complex in barium chloride (10.1371/JOURNAL.PBIO.0050121 )
• 2JK5: potassium channel kcsa in complex with tetrabutylammonium in high k (10.1021/BI500525S )
• 2NLJ: potassium channel kcsa(m96v)-fab complex in kcl (10.1371/JOURNAL.PBIO.0050121 )
• 2NTF: crystal structure of a quorum-quenching antibody in complex with an n- acyl-l-homoserine lactone analog (10.1016/J.JMB.2007.02.081 )
• 2OP4: crystal structure of quorum-quenching antibody 1g9 (10.1016/J.JMB.2007.02.081 )
• 2P7T: crystal structure of kcsa mutant
• 2UYL: crystal structure of a monoclonal antibody directed against an antigenic determinant common to ogawa and inaba serotypes of vibrio cholerae o1 (10.1002/PROT.21609 )
• 2V7H: crystal structure of an immunogen specific anti- mannopyranoside monoclonal antibody fab fragment (10.1529/BIOPHYSJ.107.108654 )
• 2VIR: influenza virus hemagglutinin complexed with a neutralizing antibody (10.1038/NSB0298-119 )
• 2VIS: influenza virus hemagglutinin, (escape) mutant with thr 131 replaced by ile, complexed with a neutralizing antibody (10.1038/NSB0298-119 )
• 2VIT: influenza virus hemagglutinin, mutant with thr 155 replaced by ile, complexed with a neutralizing antibody (10.1038/NSB0298-119 )
• 2W0F: potassium channel kcsa-fab complex with tetraoctylammonium (10.1021/BI500525S )
• 2XZQ: crystal structure analysis of the anti-(4-hydroxy-3- nitrophenyl)-acetyl murine germline monoclonal antibody bbe6.12h3 fab fragment in complex with a phage display derived dodecapeptide yqlrpnaetlrf (10.4049/JIMMUNOL.1102701 )
• 2Y06: crystal structure analysis of the anti-(4-hydroxy-3-nitrophenyl) - acetyl murine germline antibody bbe6.12h3 fab fragment in complex with a phage display derived dodecapeptide gdprpsyishll (10.4049/JIMMUNOL.1102701 )
• 2Y07: crystal structure analysis of the anti-(4-hydroxy-3- nitrophenyl) -acetyl murine germline monoclonal antibody bbe6.12h3 fab fragment in complex with a phage display derived dodecapeptide ppypawhapgni (10.4049/JIMMUNOL.1102701 )
• 2Y36: crystal structure analysis of the anti-(4-hydroxy-3- nitrophenyl)- acetyl murine germline antibody bbe6.12h3 fab fragment in complex with a phage display derived dodecapeptide dlwttaiptips (10.4049/JIMMUNOL.1102701 )
• 2ZJS: crystal structure of secye translocon from thermus thermophilus with a fab fragment (10.1038/NATURE07421 )
• 2ZPK: crystal structure of p20.1 fab fragment in complex with its antigen peptide (10.1110/PS.038299.108 )
• 3DGG: crystal structure of fabox108 (10.1016/J.PEP.2008.06.017 )
• 3DIF: crystal structure of fabox117 (10.1016/J.PEP.2008.06.017 )
• 3F5W: kcsa potassium channel in the open-inactivated state with 32 a opening at t112
• 3F7V: kcsa potassium channel in the open-inactivated state with 23 a opening at t112
• 3F7Y: kcsa potassium channel in the partially open state with 17 a opening at t112
• 3FB5: kcsa potassium channel in the partially open state with 14.5 a opening at t112
• 3FB6: kcsa potassium channel in the partially open state with 16 a opening at t112
• 3FB7: open kcsa potassium channel in the presence of rb+ ion
• 3FB8: kcsa potassium channel in the open-conductive state with 20 a opening at t112 in the presence of rb+ ion
• 3GB7: potassium channel kcsa-fab complex in li+ (10.1038/NSMB.1703 )
• 3HPL: kcsa e71h-f103a mutant in the closed state (10.1038/NATURE09136 )
• 3IGA: potassium channel kcsa-fab complex in li+ and k+ (10.1038/NSMB.1703 )
• 3KS0: crystal structure of the heme domain of flavocytochrome b2 in complex with fab b2b4 (10.1016/J.JMB.2010.05.035 )
• 3NZ8: crystal structure of the hiv-2 neutralizing fab fragment 7c8 (10.1371/JOURNAL.PONE.0018767 )
• 3OGC: kcsa e71a variant in presence of na+ (10.1073/PNAS.1014186108 )
• 3OR6: on the structural basis of modal gating behavior in k+channels - e71q (10.1038/NSMB.1968 )
• 3OR7: on the structural basis of modal gating behavior in k+channels - e71i (10.1038/NSMB.1968 )
• 3RHW: c. elegans glutamate-gated chloride channel (glucl) in complex with fab and ivermectin (10.1038/NATURE10139 )
• 3RI5: c. elegans glutamate-gated chloride channel (glucl) in complex with fab, ivermectin and picrotoxin (10.1038/NATURE10139 )
• 3RIA: c. elegans glutamate-gated chloride channel (glucl) in complex with fab, ivermectin and iodide. (10.1038/NATURE10139 )
• 3RIF: c. elegans glutamate-gated chloride channel (glucl) in complex with fab, ivermectin and glutamate. (10.1038/NATURE10139 )
• 3S35: structural basis for the function of two anti-vegf receptor antibodies (10.1016/J.STR.2011.01.019 )
• 3S62: structure of fab fragment of malaria transmission blocking antibody 2a8 against p. vivax p25 protein (10.1016/J.IJBIOMAC.2011.10.012 )
• 3STL: kcsa potassium channel mutant y82c with cadmium bound (10.1016/J.STR.2012.03.027 )
• 3STZ: kcsa potassium channel mutant y82c with nitroxide spin label (10.1016/J.STR.2012.03.027 )
• 3V4P: crystal structure of a4b7 headpiece complexed with fab act-1 (10.1083/JCB.201110023 )
• 3V4V: crystal structure of a4b7 headpiece complexed with fab act-1 and ro0505376 (10.1083/JCB.201110023 )
• 3V7A: structural basis for broad detection of genogroup ii noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle (10.1128/JVI.06868-11 )
• 3VI3: crystal structure of alpha5beta1 integrin headpiece (ligand-free form) (10.1083/JCB.201111077 )
• 3VI4: crystal structure of alpha5beta1 integrin headpiece in complex with rgd peptide (10.1083/JCB.201111077 )
• 4A6Y: crystal structure of fab fragment of anti-(4-hydroxy-3- nitrophenyl)-acetyl murine germline antibody bbe6.12h3 (10.4049/JIMMUNOL.1102701 )
• 4AMK: fab fragment of antiporphrin antibody 13g10 (10.1371/JOURNAL.PONE.0051128 )
• 4AT6: fab fragment of antiporphyrin antibody 14h7 (10.1371/JOURNAL.PONE.0051128 )
• 4BH7: crystal structure of germline antibody 36-65 in complex with peptide ppypawhapgni (10.4049/JIMMUNOL.1302143 )
• 4BH8: crystal structure of germline antibody 36-65 in complex with peptide gdprpsyishll (10.4049/JIMMUNOL.1302143 )
• 4DGI: structure of pom1 fab fragment complexed with human prpc fragment 120- 230 (10.1107/S0907444912037328 )
• 4H88: structure of pom1 fab fragment complexed with mouse prpc fragment 120- 230 (10.1038/NATURE12402 )
• 4I2X: crystal structure of signal regulatory protein gamma (sirp-gamma) in complex with fabox117 (10.1186/1472-6807-13-13 )
• 4I9W: human two pore domain k+ channel traak (k2p4.1) - fab complex structure (10.1073/PNAS.1218950110 )
• 4K2U: crystal structure of pfeba-175 f1 in complex with r218 antibody fab fragment (10.1371/JOURNAL.PPAT.1003390 )
• 4LBE: structure of kcsa with r122a mutation (10.1085/JGP.201311057 )
• 4LCU: structure of kcsa with e118a mutation (10.1085/JGP.201311057 )
• 4MA7: crystal structure of mouse prion protein complexed with promazine (10.1016/J.STR.2013.11.009 )
• 4MA8: crystal structure of mouse prion protein complexed with chlorpromazine (10.1016/J.STR.2013.11.009 )
• 4MSW: y78 ester mutant of kcsa in high k+ (10.1073/PNAS.1314356110 )
• 4OKV: crystal structure of anopheline anti-platelet protein with fab antibody
• 4OZ4: x-ray structure of the dc8e8 fab apo-form crystallized at ph 8.5 and refined to 3.0 a. (10.1186/ALZRT277 )
• 4Q0X: crystal structure of non-neutralizing antibody in complex with epitope ii of hcv e2 (10.1073/PNAS.1411317111 )
• 4QT5: crystal structure of 3bd10: a monoclonal antibody against the tsh receptor (10.1210/ME.2014-1257 )
• 4RDQ: calcium-activated chloride channel bestrophin-1, from chicken, in complex with fab antibody fragments, chloride and calcium (10.1038/NATURE13913 )
• 4RGN: structure of staphylococcal enterotoxin b bound to two neutralizing antibodies, 14g8 and 6d3 (10.1074/JBC.M114.630715 )
• 4TNV: c. elegans glutamate-gated chloride channel (glucl) in complex with fab in a non-conducting conformation (10.1038/NATURE13669 )
• 4TNW: c. elegans glutamate-gated chloride channel (glucl) in complex with fab and popc in a lipid-modulated conformation (10.1038/NATURE13669 )
• 4UUJ: potassium channel kcsa-fab with tetrahexylammonium (10.1021/BI500525S )
• 4WFE: human traak k+ channel in a k+ bound conductive conformation (10.1038/NATURE14013 )
• 4WFF: human traak k+ channel in a k+ bound nonconductive conformation (10.1038/NATURE14013 )
• 4WFG: human traak k+ channel in a tl+ bound conductive conformation (10.1038/NATURE14013 )
• 4WFH: human traak k+ channel in a tl+ bound nonconductive conformation (10.1038/NATURE14013 )
• 4YX2: crystal structure of bovine prion protein complexed with pom1 fab (10.1016/J.JSB.2015.08.014 )
• 4YXH: crystal structure of deer prion protein complexed with pom1 fab (10.1016/J.JSB.2015.08.014 )
• 4YXK: crystal structure of elk prion protein complexed with pom1 fab (10.1016/J.JSB.2015.08.014 )
• 5A2I: crystal structure of scfv-sm3 in complex with apd-sgalnac-rp (10.1002/ANIE.201502813 )
• 5A2J: crystal structure of scfv-sm3 in complex with the naked peptide apdtrp (10.1002/ANIE.201502813 )
• 5A2K: crystal structure of scfv-sm3 in complex with apd-tgalnac-rp (10.1002/ANIE.201502813 )
• 5A2L: crystal structure of scfv-sm3 in complex with apd-cgalnac-rp (10.1002/ANIE.201502813 )
• 5ANY: electron cryo-microscopy of chikungunya virus in complex with neutralizing antibody fab chk265 (10.1016/J.CELL.2015.10.050 )
• 5D8J: development of a therapeutic monoclonal antibody targeting secreted ap2 to treat type 2 diabetes. (10.1126/SCITRANSLMED.AAC6336 )
• 5E1A: structure of kcsa with l24c/r117c mutations (10.1085/JGP.201611602 )
• 5EBL: kcsa t75g in the conductive state (10.1016/J.STR.2016.02.021 )
• 5EBM: kcsa t75g mutant in the nonconductive state (10.1016/J.STR.2016.02.021 )
• 5EBW: kcsa with g77ester mutation (10.1016/J.STR.2016.02.021 )
• 5EC1: kcsa with v76ester mutation (10.1016/J.STR.2016.02.021 )
• 5EC2: kcsa with v76ester+g77da mutations (10.1016/J.STR.2016.02.021 )
• 5EPM: ceratotoxin variant in complex with specific antibody fab fragment (10.1074/JBC.M116.725978 )
• 5FXC: crystal structure of glycopeptide 22 in complex with scfv-sm3 (10.1021/ACS.JOC.6B00833 )
• 5H2B: structure of a novel antibody g196 (10.1038/SREP43480 )
• 5J9P: kcsa in vitro (10.1021/ACS.BIOCHEM.6B00488 )
• 5JHL: crystal structure of zika virus envelope protein in complex with a flavivirus broadly-protective antibody (10.1016/J.CHOM.2016.04.013 )
• 5KVF: zika specific antibody, zv-64, bound to zika envelope diii (10.1016/J.CELL.2016.07.020 )
• 5L7X: afamin antibody fragment, n14 fab, l1- glycosylated, crystal form ii (10.1107/S205979831601723X )
• 5L88: afamin antibody fragment, n14 fab, l1- glycosilated, crystal form i, non-parsimonious model (10.1107/S205979831601723X )
• 5L9D: afamin antibody fragment, n14 fab, l1- glycosylated, crystal form i, parsimonious model (10.1107/S205979831601723X )
• 5LGH: afamin antibody fragment, n14 fab, l1- glycosilated, crystal form ii, same as 5l7x, but isomorphous setting indexed same as 5l88, 5l9d (10.1107/S205979831601723X )
• 5MO3: crystal structure of dc8e8 fab in the complex with a 14-mer tau peptide at ph 8.5
• 5MP1: crystal structure of dc8e8 fab in the complex with a 14-mer tau peptide at ph 7.5
• 5MP3: crystal structure of dc8e8 fab in the complex with a 30-mer tau peptide at ph 6.5
• 5MP5: crystal structure of dc8e8 fab in the complex with a 14-mer tau peptide at ph 6.5
• 5MTH: structure of dc8e8 fab at ph 6.5 crystallized in spacegroup p21
• 5MUQ: crystal structure of dc8e8 fab at ph 7.0 containing a zn atom
• 5MVJ: structure of dc8e8 fab at ph 6.5 crystallized in space-group p1
• 5MX3: structure of dc8e8 fab crystallized at ph 8.5
• 5MYX: structure of pyroglutamate-abeta-specific fab c#24 in complex with human abeta-pe3-18 (10.1074/JBC.M117.777839 )
• 5N7B: understanding the singular conformational landscape of the tn antigens: sulfur-for- oxygen substitution in the glycosidic linkage provides new insights into molecular recognition by an antibody (10.1021/JACS.8B13503 )
• 5NST: human monoclonal antibody with a lair1 insertion (10.7554/ELIFE.27311 )
• 5OWP: crystal structure of glycopeptide "gvtsafpdt*rpap" in complex with scfv-sm3 (10.1021/JACS.7B09447 )
• 5T5F: neisseria meningitidis factor h binding protein in complex with monoclonal antibody jar5 (10.1042/BCJ20160806 )
• 5T5N: calcium-activated chloride channel bestrophin-1 (best1), triple mutant: i76a, f80a, f84a; in complex with an fab antibody fragment, chloride, and calcium (10.1073/PNAS.1614688113 )
• 5VGA: alternative model for fab 36-65 (10.1111/FEBS.14320 )
• 5VK6: open conformation of kcsa non-inactivating e71a mutant (10.7554/ELIFE.28032 )
• 5VKE: open conformation of kcsa deep-inactivated (10.7554/ELIFE.28032 )
• 5VKH: closed conformation of kcsa y82a-f103a mutant (10.7554/ELIFE.28032 )
• 5W0K: crystal structure of ebv ghgl/cl40/gp42 n-domain (10.1073/PNAS.1704661114 )
• 5XCQ: crystal structure of p20.1 fv-clasp fragment with its antigen peptide (10.1016/J.STR.2017.08.011 )
• 5XCR: crystal structure of p20.1 fv-clasp fragment with its antigen peptide (10.1016/J.STR.2017.08.011 )
• 5XCT: crystal structure of p20.1 fv-clasp fragment with its antigen peptide (10.1016/J.STR.2017.08.011 )
• 5YSL: crystal structure of antibody 1h1 fab (10.1371/JOURNAL.PPAT.1006777 )
• 6BFS: the mechanism of gm-csf inhibition by human gm-csf auto-antibodies (10.1080/19420862.2018.1494107 )
• 6BY2: closed and deep-inactivated conformation of kcsa-t75a mutant (10.1073/PNAS.1800559115 )
• 6BY3: open and conductive conformation of kcsa-t75a mutant (10.1073/PNAS.1800559115 )
• 6EWB: crystal structure of gii.4 unsw 2012 p domain in complex with fab 10e9 (10.1128/JVI.02174-18 )
• 6FAB: three-dimensional structure of murine anti-p- azophenylarsonate fab 36-71. 1. x-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten (10.1021/BI00229A022 )
• 6FRJ: crystal structure of scfv-sm3 in complex with apd-sethrgalnac-rp (10.1021/JACS.8B13503 )
• 6FZQ: crystal structure of scfv-sm3 in complex with compound 3 (10.1021/JACS.8B04801 )
• 6FZR: crystal structure of scfv-sm3 in complex with compound 2 (10.1021/JACS.8B04801 )
• 6H3H: fab fragment of antibody against fullerene c60
• 6K4Z: single-chain fv antibody of c6 complexed with 2-(4-hydroxy-3- nitrophenyl)acetic acid (10.1016/J.MOLIMM.2019.09.001 )
• 6K65: application of anti-helix antibodies in protein structure determination (9014-1p4b) (10.1073/PNAS.1910080116 )
• 6MUI: cryoem structure of chimeric eastern equine encephalitis virus with fab of eeev-42 antibody (10.1016/J.CELREP.2018.11.067 )
• 6MW9: cryoem structure of chimeric eastern equine encephalitis virus with fab of eeev-3 antibody (10.1016/J.CELREP.2018.11.067 )
• 6MWC: cryoem structure of chimeric eastern equine encephalitis virus with fab of eeev-5 antibody (10.1016/J.CELREP.2018.11.067 )
• 6MWV: cryoem structure of chimeric eastern equine encephalitis virus with fab of eeev-58 antibody (10.1016/J.CELREP.2018.11.067 )
• 6MWX: cryoem structure of chimeric eastern equine encephalitis virus with fab of eeev-69 antibody (10.1016/J.CELREP.2018.11.067 )
• 6N5B: broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope (10.1016/J.CHOM.2019.04.003 )
• 6N5D: broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope (10.1016/J.CHOM.2019.04.003 )
• 6N5E: broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope (10.1016/J.CHOM.2019.04.003 )
• 6NFU: structure of the kcsa-g77a mutant or the 2,4-ion bound configuration of a k+ channel selectivity filter. (10.1073/PNAS.1901888116 )
• 6NFV: structure of the kcsa-g77c mutant or the 2,4-ion bound configuration of a k+ channel selectivity filter. (10.1073/PNAS.1901888116 )
• 6O9I: ternary complex of mouse ecd with fab1 and fab2 (10.1080/19420862.2019.1710047 )
• 6OHG: structure of plasmodium falciparum vaccine candidate pfs230d1m in complex with the fab of a transmission blocking antibody (10.1038/S42003-020-01123-9 )
• 6OL5: structure of iglb12 fab in complex with anti-idiotype ib3 fab (10.1084/JEM.20190164 )
• 6P4Y: crystal structure of anti-il-7ralpha 4a10 fab (10.1038/S41375-019-0531-8 )
• 6P50: crystal structure of a complex of human il-7ralpha with an anti-il- 7ralpha fab 4a10 (10.1038/S41375-019-0531-8 )
• 6PA0: structure of the g77a mutant in sodium chloride (10.1073/PNAS.1901888116 )
• 6S5A: crystal structure of fc p329g lala with anti fc p329g fab (10.1093/PROTEIN/GZZ027 )
• 6SF6: crystal structure of the mab 15a in complex with comp-epitope p6
• 6SHG: diffraction data for roab13 crystal co-crystallised with piydin and its roab13 structure
• 6TGG: scfv-1sm3 in complex with glycopeptide containing an sp2-imino sugar (10.1039/C9SC06334J )
• 6VYV: human mabs broadly protect against infection of arthritiogenic alphaviruses by recognizing conserved elements of the mxr8 receptor binding domain (10.1016/J.CHOM.2020.07.008 )
• 6W09: human mabs broadly protect against infection of arthritiogenic alphaviruses by recognizing conserved elements of the mxr8 receptor binding domain (10.1016/J.CHOM.2020.07.008 )
• 6W0A: open-gate kcsa soaked in 1 mm bacl2 (10.1016/J.JMB.2020.06.012 )
• 6W0B: open-gate kcsa soaked in 2 mm bacl2 (10.1016/J.JMB.2020.06.012 )
• 6W0C: open-gate kcsa soaked in 4 mm bacl2 (10.1016/J.JMB.2020.06.012 )
• 6W0D: open-gate kcsa soaked in 5 mm bacl2 (10.1016/J.JMB.2020.06.012 )
• 6W0E: open-gate kcsa soaked in 10 mm bacl2 (10.1016/J.JMB.2020.06.012 )
• 6W0F: closed-gate kcsa soaked in 0mm kcl/5mm bacl2 (10.1016/J.JMB.2020.06.012 )
• 6W0G: closed-gate kcsa soaked in 1mm kcl/5mm bacl2 (10.1016/J.JMB.2020.06.012 )
• 6W0H: closed-gate kcsa soaked in 5mm kcl/5mm bacl2 (10.1016/J.JMB.2020.06.012 )
• 6W0I: closed-gate kcsa soaked in 10mm kcl/5mm bacl2 (10.1016/J.JMB.2020.06.012 )
• 6W0J: closed-gate kcsa incubated in bacl2/nacl (10.1016/J.JMB.2020.06.012 )
• 6W1C: human mabs broadly protect against infection of arthritiogenic alphaviruses by recognizing conserved elements of the mxr8 receptor binding domain (10.1016/J.CHOM.2020.07.008 )
• 6WN4: structural basis for the binding of monoclonal antibody 5d2 to the tryptophan-rich lipid-binding loop in lipoprotein lipase (10.1194/JLR.RA120000993 )
• 6WT3: structural basis for the binding of monoclonal antibody 5d2 to the tryptophan-rich lipid-binding loop in lipoprotein lipase (10.1194/JLR.RA120000993 )
• 6XR0: crystal structure of human melanotransferrin in complex with sc57.32 fab (10.1038/S41598-020-79090-8 )
• 6Z2L: structure of plasmodium falciparum p113 bound to antibody p3.2 (10.1128/MBIO.01566-20 )
• 6Z7W: human insulin in complex with the analytical antibody hui-018 fab (10.1002/PRO.4009 )
• 7C81: e30 f-particle in complex with 6c5 (10.1038/S41467-020-18250-W )
• 7CMK: e30 e-particle in complex with 6c5 (10.1038/S41467-020-18250-W )
• 7DNH: 2-fold subparticles refinement of human papillomavirus type 58 pseudovirus in complexed with the fab fragment of 2h3 (10.1128/JVI.01587-20 )
• 7E6P: fab-amyloid beta fragment complex (10.1021/ACSCHEMNEURO.1C00416 )
• 7FCI: human ntcp in complex with yn69083 fab (10.1038/S41586-022-04857-0 )
• 7JIX: murine antibody that engages the influenza hemagglutinin receptor binding site
• 7JTI: interphotoreceptor retinoid-binding protein (irbp) in complex with a monoclonal antibody (f3f5 mab5) (10.1096/FJ.202000796RR )
• 7K9H: sars-cov-2 spike in complex with neutralizing fab 2b04 (one up, two down conformation)
• 7K9I: sars-cov-2 spike rbd in complex with neutralizing fab 2b04 (local refinement)
• 7LJ4: human traak k+ channel fheig mutant a270p in a k+ bound conductive conformation (10.1101/2021.06.04.447000 )
• 7LJ5: human traak k+ channel fhieg mutant a198e in a k+ bound conductive conformation (10.1101/2021.06.04.447000 )
• 7LJA: human traak k+ channel fheig mutant a198e in a tl+ bound conductive conformation (10.1101/2021.06.04.447000 )
• 7LJB: human traak k+ channel mutant g158d in a k+ bound conductive conformation (10.1101/2021.06.04.447000 )
• 7M2H: structural snapshots of intermediates in the gating of a k+ channel (10.1016/J.JMB.2021.167296 )
• 7M2I: structural snapshots of intermediates in the gating of a k+ channel (10.1016/J.JMB.2021.167296 )
• 7M2J: structural snapshots of intermediates in the gating of a k+ channel (10.1016/J.JMB.2021.167296 )
• 7MHR: kcsa e71v closed gate with k+ (10.1038/S41467-022-28866-9 )
• 7MHX: kcsa e71v closed gate with ba2+ (10.1038/S41467-022-28866-9 )
• 7NX2: unbound antigen-binding fragment (fab) 324 (10.1038/S41586-021-03959-5 )
• 7NX3: crystal structure of alk in complex with fab324 (10.1038/S41586-021-03959-5 )
• 7QU1: machupo virus gp1 glycoprotein in complex with fab fragment of antibody mac1
• 7RP0: structural snapshots of intermediates in the gating of a k+ channel (10.1016/J.JMB.2021.167296 )
• 7TE1: sars-cov-2 receptor binding domain in complex with ab17 (10.1016/J.CELREP.2022.110561 )
• 7WD8: sars-cov-2 beta spike sd1 in complex with s3h3 fab (10.1080/22221751.2021.2024455 )
• 7WD9: sars-cov-2 beta spike in complex with three s3h3 fabs (10.1080/22221751.2021.2024455 )
• 7WDF: sars-cov-2 beta spike in complex with two s3h3 fabs (10.1080/22221751.2021.2024455 )
• 7WK8: sars-cov-2 omicron spike protein sd1 in complex with s3h3 fab
• 7WK9: sars-cov-2 omicron open state spike protein in complex with s3h3 fab
• 7WKA: sars-cov-2 omicron closed state spike protein in complex with s3h3 fab